Table 5.

Cost breakdown avelumab + BSC vs. BSC alone (discounted 4%)

Costs, €	Avelumab + BSC	BSC	Incremental
Drug acquisition (first-line)	57,364	0	57,364
Drug administration (first-line)	4226	0	4226
Adverse event management	239	153	86
Medical resource use	14,474	11,931	2544
Subsequent treatment	4983	24,703	− 19,720
End of life	5735	5955	− 220
Informal care giving	23,293	19,597	3696
Travel	419	208	210
Total	110,734	62,548	48,186

BSC best supportive care